The antipyretic effectiveness of dipyrone in the intensive care unit: A retrospective cohort study.

Hans-Joerg GillmannJessica ReichartAndreas LefflerThomas Stueber

Published in: PloS one (2022)

Antipyretic effectiveness of dipyrone in ICU patients may be overestimated. Given the lack of prospective data, clinical evidence for antipyretic dipyrone therapy in the ICU is insufficient and warrants further critical evaluation.

Keyphrases

intensive care unit
randomized controlled trial
end stage renal disease
systematic review
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
patient reported outcomes
data analysis
smoking cessation
replacement therapy